(O3-M1) αPD-1 blockade shifts the dynamic equilibrium of the dynamically formed PD-1:PD-L1 bonds toward unbound forms of both PD-L1 and PD-1, allowing anti-tumor TEFF to recover from immunologic paralysis and to gain motility. Here, PDCD1 is linked to neoplasm.